Imfinzi BTC Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - CEI/SCEI

Trial Identifier: D933AC00005
Sponsor: AstraZeneca
Start Date: June 2023
Primary Completion Date: July 2026
Study Completion Date: July 2026
Condition: Liver Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Japan Aomori, Japan
Japan Ehime, Japan
Japan Fukui, Japan
Japan Fukushima, Japan
Japan Hokkaido, Japan
Japan Iwate, Japan
Japan Kagawa, Japan
Japan Kyoto, Japan
Japan Nagano, Japan
Japan Nagasaki, Japan
Japan Nara, Japan
Japan Okayama, Japan
Japan Okinawa, Japan
Japan Shiga, Japan
Japan Shimane, Japan
Japan Shizuoka, Japan
Japan Tochigi, Japan
Japan Tottori, Japan
Japan Yamaguchi, Japan